<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034510</url>
  </required_header>
  <id_info>
    <org_study_id>203/2019/Disp/AOUFe</org_study_id>
    <nct_id>NCT05034510</nct_id>
  </id_info>
  <brief_title>Short Pulse Width Versus Low Frequency DBS in Parkinson's Disease</brief_title>
  <official_title>A Double-Blind Randomized Crossover Comparison Of Short Pulse Width Versus Low Frequency For Axial Symptoms In Subthalamic Nucleus Deep Brain Stimulation (DBS)-Implanted Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to compare the effect of reducing the conventional pulse width or frequency of&#xD;
      stimulation for axial symptoms occurring after Subthalamic nucleus Deep Brain Stimulation&#xD;
      (STN DBS) treatment. The participants will be assessed with chronic stimulation with&#xD;
      conventional stimulation parameters, namely 60 us and 130 Hz, and after random allocation to&#xD;
      short pulse width (30 us) or low frequency (80 Hz).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      STN-DBS implanted patient frequently develop axial symptoms, such as gait and speech&#xD;
      disorders, after this surgical procedure, which dampens long-term quality of life of&#xD;
      Parkinson's disease patients. The pathogenesis is not completely understood, as it could be&#xD;
      either due to a long-term stimulation side effect or a symptom with later onset in disease&#xD;
      progression which is not well controlled with actual stimulation program. In case of freezing&#xD;
      of gait onset in STN-DBS, literature suggest reducing stimulation frequency. Although, low&#xD;
      pulse width is a promising option to tackle speech disorders after STN implant, it is not&#xD;
      known its potential therapeutic potential on freezing of gait.&#xD;
&#xD;
      The aim of this investigation is to compare the effect of low frequency and short pulse width&#xD;
      stimulation in patients, who develop axial symptoms during long-term follow-up in chronic&#xD;
      conventional STN DBS.&#xD;
&#xD;
      As per protocol, participants will be assessed at baseline with chronic standard stimulation&#xD;
      parameters (60 us and 130 Hz) then they will be randomly allocated either to a low-frequency&#xD;
      (80Hz) or a low-pulse arm (30 us). The study is designed such that after scheduled&#xD;
      re-assessment the participant will be switched from low frequency arm to short pulse width&#xD;
      and vice versa according to the crossover nature of protocol design. Both the rating&#xD;
      investigator and the participant are blinded to the allocation, whereas an unblinded&#xD;
      investigator will modify the parameters according to allocation arm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2021</start_date>
  <completion_date type="Anticipated">March 20, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freezing of gait incidence reduction</measure>
    <time_frame>4 weeks</time_frame>
    <description>reduction of freezing of gait incidence as measured by Freezing of Gait Questionnaire item-3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of freezing ratio</measure>
    <time_frame>4 weeks</time_frame>
    <description>reduction in freezing ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of freezing of gait duration</measure>
    <time_frame>4 weeks</time_frame>
    <description>reduction of composite measure from item-4, item-5 and item-6 of Freezing of Gait Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in speech quality</measure>
    <time_frame>4 weeks</time_frame>
    <description>reduction in Movement Disorder Society UPDRS item 3.1</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Low frequency 80 Hz then short pulse width 30 usec stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each participant will undergo to low frequency stimulation for 4 weeks, then will switch to short pulse width stimulation paradigm for 4 weeks according to the crossover design.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short pulse width 30 usec then low frequency 80 Hz stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each participant will undergo to short pulse width stimulation paradigm for 4 weeks, then will switch to low frequency for 4 weeks according to the crossover design.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>modification in stimulation parameters</description>
    <arm_group_label>Low frequency 80 Hz then short pulse width 30 usec stimulation</arm_group_label>
    <arm_group_label>Short pulse width 30 usec then low frequency 80 Hz stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Parkinson's disease&#xD;
&#xD;
          -  Subthalamic Nucleus Deep Brain Stimulation with chronic conventional stimulation at 60&#xD;
             usec and 130 Hz for at least 3 months&#xD;
&#xD;
          -  Movement Disorder Society UPDRS part III 3.11 &gt;1&#xD;
&#xD;
          -  Freezing of Gait Questionnaire item-3 &gt;1&#xD;
&#xD;
          -  Movement Disorder Society UPDRS part III 3.1 &gt;1&#xD;
&#xD;
          -  Montreal Cognitive Assessment &gt; 26&#xD;
&#xD;
          -  No psychiatric disorders&#xD;
&#xD;
          -  All patients will be â‰¥ 18 years of age&#xD;
&#xD;
          -  Documented informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no documented informed consent&#xD;
&#xD;
          -  axial disorders not related to Parkinson's disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariachiara Sensi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero Universitaria di Ferrara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariachiara Sensi, PhD</last_name>
    <phone>0039-0532-237540</phone>
    <email>mc.sensi@ospfe.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Ferrara - Arcispedale Sant'Anna</name>
      <address>
        <city>Ferrara</city>
        <state>Emilia Romagna</state>
        <zip>44122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariachiara Sensi, PhD</last_name>
      <phone>0039-0532-237540</phone>
      <email>mc.sensi@ospfe.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 27, 2021</study_first_submitted>
  <study_first_submitted_qc>August 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DBS</keyword>
  <keyword>Parkinson's disease</keyword>
  <keyword>low frequency</keyword>
  <keyword>short pulse width</keyword>
  <keyword>axial symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

